Titlebook: Management of Differentiated Thyroid Cancer; Anne T. Mancino,Lawrence T. Kim Book 2017 The Editor(s) (if applicable) and The Author(s) 201

Inspection

書目名稱Management of Differentiated Thyroid Cancer影響因子(影響力)




書目名稱Management of Differentiated Thyroid Cancer影響因子(影響力)學(xué)科排名




書目名稱Management of Differentiated Thyroid Cancer網(wǎng)絡(luò)公開(kāi)度




書目名稱Management of Differentiated Thyroid Cancer網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書目名稱Management of Differentiated Thyroid Cancer被引頻次




書目名稱Management of Differentiated Thyroid Cancer被引頻次學(xué)科排名




書目名稱Management of Differentiated Thyroid Cancer年度引用




書目名稱Management of Differentiated Thyroid Cancer年度引用學(xué)科排名




書目名稱Management of Differentiated Thyroid Cancer讀者反饋




書目名稱Management of Differentiated Thyroid Cancer讀者反饋學(xué)科排名

ERUPT

樂(lè)器演奏者

Book 2017 with an interest in thyroid cancer. The book reviews new data about molecular genetics and molecular diagnostic approaches,?covers diagnosis and treatment of localized disease, and conventional and newer therapies for dealing with recurrent and metastatic disease. Areas of controversy, with expert

Diastole

al information.This text provides a comprehensive, state-of-the art review of this field, and serves as a valuable resource for clinicians, surgeons and researchers with an interest in thyroid cancer. The book reviews new data about molecular genetics and molecular diagnostic approaches,?covers diag

deriver

Clinical Presentation and Diagnosis of Papillary Thyroid Cancer,ints are the extent of surgery and the management of lymph nodes. A rational approach to the workup of thyroid nodules and the management of thyroid cancer is needed to curb the growing epidemic of overdiagnosis.

Arresting

Clinical Presentation and Diagnosis of Follicular Thyroid Cancer,d-stimulating hormone suppression. Prognosis is generally favorable with 5-year survival ranging between 71 and 94% and 10-year survival between 43 and 95%. Negative prognostic factors include older age, tumor size, vascular invasion, degree of invasion, metastatic disease, and incomplete resection.

finale

壯觀的游行

Jejune

The Debate , Elective Lymph Node Dissection in Papillary Thyroid Carcinoma,de dissection is a safe procedure with multiple benefits to the patient and clinician and should be performed routinely in addition to thyroidectomy for patients with primary papillary thyroid carcinoma >1 cm.

tendinitis